ArKal Medical Obtains $17,500,000 Series B Funding

  • Feed Type
  • Date
    9/16/2008
  • Company Name
    ArKal Medical
  • Mailing Address
    46575 Fremont Blvd Fremont, CA 94538
  • Company Description
    ArKal Medical is developing a novel continuous glucose monitoring system for the management of diabetes. ArKal’s monitoring system is designed to eliminate many of the inconveniences of current glucose monitoring technologies.
  • Website
    http://www.arkalmed.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $17,500,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Thomas, McNerny & Partners
  • Venture Investor
    Delphi Ventures
  • Venture Investor
    Medventure Associates

By posting a comment, you agree to our terms and conditions.